Results 1 to 10 of about 2,967,484 (341)

OTULIN protects the intestinal epithelium from apoptosis during inflammation and infection

open access: yesCell Death and Disease, 2023
The intestinal epithelium is a single cell layer that is constantly renewed and acts as a physical barrier that separates intestinal microbiota from underlying tissues.
Lien Verboom   +10 more
doaj   +1 more source

NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis

open access: yesCell Death and Disease, 2023
Plasma membrane permeabilization (PMP) is a defining feature of regulated necrosis. It allows the extracellular release of damage-associated molecular patterns (DAMPs) that trigger sterile inflammation. The pore forming molecules MLKL and GSDMs drive PMP
Yves Dondelinger   +5 more
doaj   +1 more source

Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice

open access: yesScientific Reports, 2023
A20 serves as a critical brake on NF-κB-dependent inflammation. In humans, polymorphisms in or near the TNFAIP3/A20 gene have been linked to various inflammatory disorders, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA ...
Karel F. A. Van Damme   +17 more
doaj   +1 more source

OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity

open access: yesNature Communications, 2021
OTULIN is a deubiquitinase for linear ubiquitin chains. Here the authors show, using genetic mouse models and single-cell RNA-sequencing, that deficiency of OTULIN in keratinocytes causes skin inflammation and verrucous carcinoma via the induction of ...
Esther Hoste   +16 more
doaj   +1 more source

Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes

open access: yesJournal of Neuroinflammation, 2023
Hepatic encephalopathy (HE) is a common complication of liver cirrhosis, associated with high morbidity and mortality, for which no brain-targeted therapies exist at present.
Wouter Claeys   +10 more
doaj   +1 more source

EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases

open access: yesEJNMMI Research, 2021
Inflammatory musculoskeletal diseases represent a group of chronic and disabling conditions that evolve from a complex interplay between genetic and environmental factors that cause perturbations in innate and adaptive immune responses. Understanding the
Erik H. J. G. Aarntzen   +10 more
doaj   +1 more source

Low-grade peripheral inflammation affects brain pathology in the App NL-G-F mouse model of Alzheimer’s disease

open access: yesActa Neuropathologica Communications, 2021
Alzheimer’s disease (AD) is a chronic neurodegenerative disease characterized by the accumulation of amyloid β (Aβ) and neurofibrillary tangles. The last decade, it became increasingly clear that neuroinflammation plays a key role in both the initiation ...
Junhua Xie   +10 more
doaj   +1 more source

Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL

open access: yesCell Death and Disease, 2021
RIPK3 was reported to play an important role in the protection against influenza A virus (IAV) in vivo. Here we show that the requirement of RIPK3 for protection against IAV infection in vivo is only apparent within a limited dose range of IAV challenge.
Teodora Oltean   +7 more
doaj   +1 more source

CARD14 Signalling Ensures Cell Survival and Cancer Associated Gene Expression in Prostate Cancer Cells

open access: yesBiomedicines, 2022
Prostate cancer (PCa) is one of the most common cancer types in men and represents an increasing global problem due to the modern Western lifestyle. The signalling adapter protein CARD14 is specifically expressed in epithelial cells, where it has been ...
Domien Vanneste   +9 more
doaj   +1 more source

Therapeutic Efficacy of Flavonoids in Allergies: A Systematic Review of Randomized Controlled Trials

open access: yesJournal of Immunology Research, 2022
Objective. To assess the clinical efficacy of flavonoid supplements on allergic diseases. Design. Systematic review. Data Sources. MEDLINE/PubMed, Scopus, Web of Science, and Embase databases were searched from inception to September 2021.
Poliana Guiomar de Almeida Brasiel   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy